Beth Israel Deaconess Department Of Medicine is categorized under Hospitals in Boston, MA and active since 2011.
Beth Israel Deaconess Department Of Medicine was established in 2011, and today employs 1 to 4, earning Unknown per year. This is a Hospitals business, which does work in the B2C market, and is classified as a Hospitals, under code number 622110 by the NAICS.
If you are seeking more information, feel free to contact Matthew Nivison at the company’s single location by writing to 330 Brookline Avenue, Boston, Massachusetts MA 02215 or by phoning (617) 667-1050. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Beth Israel Deaconess Department Of Medicine |
| Contact Person: | Matthew Nivison |
| Address: | 330 Brookline Avenue, Boston, Massachusetts 02215 |
| Phone Number: | (617) 667-1050 |
| Annual Revenue (USD): | Unknown |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hospitals |
| SIC Code: | 8062 |
| NAICS Code: | 622110 |
| Share This Business: |
Beth Israel Deaconess Department Of Medicine was started in 2011 to provide professional Hospitals under the SIC code 8062 and NAICS code 622110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Matthew Nivison for inquiries that concern Beth Israel Deaconess Department Of Medicine by calling the company number (617) 667-1050, as your correspondence is most welcome. Additionally, the physical location of the single location of Beth Israel Deaconess Department Of Medicine can be found at the coordinates 42.340894,-71.104931 as well as the street address 330 Brookline Avenue in Boston, Massachusetts 02215.
For its online presence, you may visit Beth Israel Deaconess Department Of Medicine’s website at and engage with its social media outlets through on Twitter and on Facebook.